| Code | 9573E | ||||||||||
| MA number | 44/0124/25-S | ||||||||||
| Product Form: | cps mol 30x1x100 mg (blis. OPA/Al/PVC/Al) - jednotk.bal. | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 08.05.2025 |
| Validity: | 08.05.2030 |
| SPC: |
SPC_Gevesla_04_2025.pdf
|
| PIL: |
PIL_Gevesla 100mg_04_2025.pdf
|
| Safety feature | Yes |
| Data update: | 13.05.2025 |
